24th Pharmaceutical & Medical Device Ethics & Compliance Congress Features Katie Gray, PharmD, Acting Director, FDA Office of Prescription Drug Promotion

24th Pharmaceutical & Medical Device Ethics & Compliance Congress Features Katie Gray, PharmD, Acting Director, FDA Office of Prescription Drug Promotion

A Hybrid Onsite Conference and Internet Event

Sponsored by Pharmaceutical Compliance Forum

Media Partners: Policy & Medicine Compliance Update

October 25-27, 2023

Gaylord National Resort & Convention Center

National Harbor, MD

www.PharmaCongress.com

PRESS RELEASE
Phone: 800-503-7419
Email: reginfo@hcconferences.com
Website: www.PharmaCongress.com

FEATURING

Catherine (Katie) Gray, PharmD
Acting Director, Office of Prescription Drug Promotion, US Food and Drug Administration, Baltimore, MD

WASHINGTON, DC USA -- PHARMA UPDATE NEWS SERVICE™ -- MAY 11, 2023: The Pharmaceutical Compliance Forum (PCF) executive committee is pleased to announce that the Twenty-Fourth Pharmaceutical & Medical Device Ethics and Compliance Congress will be held at the Gaylord National Resort & Convention Center, National Harbor, MD.

KEYNOTE SPEAKERS

Robert K. DeConti, JD
Chief Counsel to the Inspector General, Office of Counsel to the Inspector General, Office of the Inspector General, US Department of Health and Human Services, Washington, DC

Kristy Grant-Hart, JD, CCEP-I
Founder and CEO, Spark Compliance; Former Chief Compliance Officer, United International Pictures; Director of Compliance, Europe, MEA, Carlson Wagonlit Travel, Los Angeles, CA

Catherine (Katie) Gray, PharmD
Acting Director, Office of Prescription Drug Promotion, US Food and Drug Administration, Baltimore, MD

Mary E. Riordan, JD
Senior Counsel, Office of Counsel to the Inspector General, Office of the Inspector General, US Department of Health and Human Services, Washington, DC

Richard Simkin
Chief Commercial Officer, Indivior; Former President North America, Reckitt Benckiser Pharmaceuticals, Richmond, VA

THE CONGRESS FEATURES

An Invitation-only Chief Compliance Officer Roundtable
Annual OIG Keynote Addresses by DOJ, FDA and OIG
Annual AUSA and Senior Ethics & Compliance Professionals Roundtable
A Faculty of over 100 & over 40 Substantive Sessions
An Industry-only Day Focused on Best Practice Exchange
Numerous Networking Opportunities

FEATURED FACULTY

Suneal Bedi, JD, PhD Assistant Professor OF Business Law & Ethic, Kelley School of Business, Indiana University, Bloomington, IN	Eric Bolesh Chief Operating Officer, Cutting Edge Information, Research Triangle Park, NC	Eve M. Brunts, JD, LLM Partner, Ropes & Gray, Boston, MA
Terra Buckley, JD Vice President, Head of Compliance Advisory Services, MedPro Systems, Summit, NJ	Greg Demske, JD Partner, Goodwin Procter LLP; Former Chief Counsel, HHS Office of Inspector General, Washington, DC	Stefanie A. Doebler, JD Partner and Co-chair, Health Care Practice Group, Covington & Burling LLP, Washington, DC
J. Mark Farrar, CPA, CFE, CFF, MSJ, CIPP/US Managing Director, Epsilon Life Sciences LLC, Atlanta, GA	Alison Fethke, JD Counsel, Ropes & Gray, LLP, Former Counsel, Legal Regulatory & Compliance, Abbvie, Chicago, IL	Pat Fogarty, JD Deputy General Counsel & Senior Vice President of Legal, AdvaMed; Former Compliance Officer & Assistant General Counsel, BIO, Washington, DC
Sarah A. Franklin, JD Partner and Vice-chair, Life Sciences Investigations Practice, Covington & Burling LLP, Washington, DC	Gary F. Giampetruzzi, JD Partner & Global Chair Life Sciences Department, Paul Hastings; Former VP, Assistant GC, Pfizer, New York, NY	Margaux J. Hall, JD Partner, Ropes & Gray, LLP, Washington, DC
Todd Haugh, JD Associate Professor of Business Law and Ethics, Indiana University, Bloomington, IN	Emily F. Hodge, JD Partner, Choate, Hall & Stewart LLP, Boston, MA	Michael K. Loucks, JD Partner, Skadden, Arps, Slate, Meagher & Flom LLP; Former Acting US Attorney, Massachusetts, US Department of Justice, Boston, MA
Kirsten Mayer, JD Interim Legal Director, ACLU of Massachusetts; Former Head, US Compliance & VP Legal, argenx; Former Partner, Ropes & Gray LLP, Boston, MA	Kevin McAnaney, JD Law Office of Kevin McAnaney; Former Chief, Industry Guidance Branch, HHS Office of Counsel to the Inspector General, Bethesda, MD	Daniel O’Connor Senior Vice President, NXLevel Compliance, Lambertville, NJ
Nikki Reeves, JD Partner & Co-chair, Life Sciences and Healthcare Industry Group, King & Spalding, Washington, DC	Jeff Rosenbaum, MBA Partner & Co-Founder, Dovetail Consulting Group; Former SVP, Chief Compliance and Risk Officer, Shire, Boston, MA	Ann-Marie Tejcek, MA Associate Vice President Global Medical Affairs, Strategy & Transformation, Eli Lilly, Indianapolis, IN
Gregg Shapiro, JD Founder, Gregg Shapiro Law, LLC; Former Assistant US Attorney and Chief, Affirmative Civil Enforcement Unit, US Attorney's Office, District of Massachusetts, Boston, MA	Michael L. Shaw, JD Principal, Global Head of Risk & Compliance, ZS; Former Vice President and Compliance Officer, Global Therapy Areas and US Pharma, GlaxoSmithKline, Princeton, NJ	James Sheehan, JD Chief, Charities Bureau at Attorney General of New York; Former Chief Integrity Officer, City of New York Human Resources Administration; Former NY Medicaid Inspector General; Former Associate United States Attorney, Eastern District of Pennsylvania, New York, NY
Paul Silver Principal and Corporate Intelligence Services Practice Leader, Deloitte Advisory, Atlanta, GA	L. Stephan Vincze, JD, LLM, MBA President & CEO, TRESTLE Compliance; Former Sr. VP and CCO, Warner Chilcot; Former VP, Ethics & Compliance Officer, TAP Pharmaceutical, Boston, MA	Julie Ritchie Wagner, JD Senior Assistant General Counsel, PhRMA; Former Senior Counsel, HHS Office of Counsel to the Inspector General, Washington, DC

PCF EXECUTIVE COMMITTEE

Joe Zimmerman
Senior Vice President, Chief Compliance Officer, SpringWorks Therapeutics
(PCF Chair)

Christie Camelio
Chief Compliance and Risk Officer, EQRx

Jill Dailey, JD
Vice President & Chief Compliance Officer, Incyte

Cheryl Lee, MBA
Vice President, Head of Major Markets Compliance & Ethics, Bristol Myers Squibb

Joshua Marks, JD
Global Head of Ethics & Compliance Program and Governance, Takeda Pharmaceuticals

Donna White, CCEP
Vice President, Compliance Officer, Chiesi

MEDICAL DEVICE STEERING COMMITTEE CO CHAIRS

Sujata Dayal, JD
Vice President & Global Chief Compliance Officer, Medline Industries, Inc.

Tara Shewchuk, JD
Chief Ethics & Compliance Officer, Medtronic

Daniel Spicehandler, JD
Vice President Compliance, Commercial Divisions, Stryker

FEATURING THE PHARMA CONGRESS ADVANCED VIRTUAL STREAMING PLATFORM

PRESENTATION PROPOSALS

Click here to submit a presentation proposal.

SPONSORED BY

PRODUCED BY

GRANTORS

SILVER

BRONZE

EXHIBITOR

MEDIA PARTNERS

CONTINUING EDUCATION CREDITS

COMPLIANCE CERTIFICATION BOARD CONTINUING EDUCATION UNITS (CCB CEUs)
The Congress is applying for approval for Compliance Certification Board (CCB)® Continuing Education Units

CONTINUING LEGAL EDUCATION
The Congress is applying for approval for Pennsylvania CLE Credits.

CERTIFICATE OF ATTENDANCE
Attendees may download and self-complete a certificate of attendance which will be posted on the Summit virtual video broadcast platform to file with appropriate certifying bodies which accept such. Click here for more information.

CONGRESS REGISTRATION

For Congress registration information, visit https://www.pharmacongress.com/registration-splash/, email reginfo@hcconferences.com, or call 800-503-7419.

CONGRESS EXHIBIT & SPONSORSHIP INFORMATION

For sponsorship and exhibit information contact Suzanne Tyler, Exhibit Manager, at (206) 244-4861 phone, (206) 319-5303 fax, or exhibits@hcconferences.com.

FOR E-MAIL ADDRESS CHANGE, ADD OR DELETE REQUESTS

For changes or additions, please email your request to: listmgr@PharmaUpdateNewsService.com.

For removal of your e-mail address, please click the link below for "SafeUnsubscribe" to automatically remove your address from the list.